“First Experience in Switzerland in Phe508del Homozygous Cystic Fibrosis Patients With End-Stage Pulmonary Disease Enrolled in a Lumacaftor-Ivacaftor Therapy Trial – Preliminary Results”. Swiss Medical Weekly, vol. 148, no. 0708, Feb. 2018, p. w14593, https://doi.org/10.4414/smw.2018.14593.